Division of Nephrology, Department of Medicine, Sidney Kimmel School of Medicine, Thomas Jefferson University, 833 Chestnut Street, Suite 700, Philadelphia, PA, 19107, USA.
Curr Hypertens Rep. 2017 May;19(5):43. doi: 10.1007/s11906-017-0739-9.
Hypertension is the leading factor in the global burden of disease. It is the predominant modifiable risk factor for stroke, heart disease, and kidney failure. Chronic kidney disease (CKD) is both a common cause and sequel of uncontrolled hypertension. The pathophysiology of CKD-associated hypertension is complex and multi-factorial. This paper reviews the key pathogenic mechanisms of CKD-associated hypertension, the importance of standardized blood pressure (BP) measurement in establishing the diagnosis and management plus the significance of ambulatory BP monitoring for assessment of diurnal BP variation commonly seen in CKD. The optimal BP target in CKD remains a matter of discussion despite recent clinical trials. Medical therapy can be difficult and challenging. In addition to lifestyle modification and dietary salt restriction, treatment may need to be individualized based on co-morbidities. Combination of antihypertensive drugs, including appropriate diuretic choice and dose, is of great significance in hypertension management in CKD.
高血压是全球疾病负担的主要因素。它是中风、心脏病和肾衰竭的主要可改变风险因素。慢性肾脏病(CKD)既是未得到控制的高血压的常见原因也是其后果。CKD 相关高血压的病理生理学复杂且多因素。本文综述了 CKD 相关高血压的关键发病机制、标准化血压(BP)测量在确立诊断和管理中的重要性以及动态血压监测在评估 CKD 中常见的日间 BP 变化的意义。尽管最近进行了临床试验,但 CKD 中的最佳 BP 目标仍然存在争议。药物治疗可能困难且具有挑战性。除了生活方式的改变和盐限制饮食外,还可能需要根据合并症来个体化治疗。在 CKD 的高血压管理中,联合使用降压药物,包括适当的利尿剂选择和剂量,具有重要意义。